Abiopharma

News list

Lehr Donald P. 🟡 adjusted position in 2.5K shares (1 derivative) of PRECIGEN, INC. (PGEN) at $7.20 Transaction Date: Aug 23, 2026 | Filing ID: 012874

Full text

News bot Aug. 25, 2026, 9:29 p.m.
🔍 Lehr Donald P. (Executive)

Company: PRECIGEN, INC. (PGEN)

Report Date: 2026-08-23
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 5,208
- Total shares sold: 7,696
Detailed Transactions and Holdings:
- Acquired 5,208 shares of Common Stock (Direct)
  Date: 2026-08-23 | Code: M | equity_swap_involved: 0 | shares_owned_after: 760,669.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 2,488 shares of Common Stock at $7.2 per share (Direct)
  Date: 2026-08-23 | Code: F | equity_swap_involved: 0 | shares_owned_after: 758,181.00 | transaction_form_type: 4 | Footnotes: F2
- Sold 5,208 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-23 | Code: M | equity_swap_involved: 0 | shares_owned_after: 57,292.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3
Footnotes:
- F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
- F2: Represents the number of shares of Precigen common stock withheld by the Issuer to satisfy income tax withholding obligations in connection with the settlement of the RSUs.
- F3: Represents 1/24 of the RSUs granted on June 26, 2025 that vested on August 23, 2026.